| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/26/2004 | US20040167229 lowering C-reactive protein; compounds such as 6,6'-oxybis(2,2-dimethylhexanoic acid) |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167226 Analgesics; neuropathic pain; central nervous system disorders; antiarthritic agents |
| 08/26/2004 | US20040167225 Processes for the preparation of oral dosage formulations of modafinil |
| 08/26/2004 | US20040167224 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 08/26/2004 | US20040167223 Topical antibacterial formulations |
| 08/26/2004 | US20040167222 Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA) |
| 08/26/2004 | US20040167221 Mixture in solvent such as ethylene glycol, propylene glycol, isopropanol; killing microorganisms on udder of milk producing animal |
| 08/26/2004 | US20040167220 Application of solutions of preservative acids or weakly alkaline preservative salts in a buffered acidic aqueous medium |
| 08/26/2004 | US20040167219 Carnitine-magnesium hydroxycitrate |
| 08/26/2004 | US20040167218 Ophthalmic fluid |
| 08/26/2004 | US20040167217 Brain disorders; central nervous system disorders; antiischemic agents; hyperglycemic agents; anoxia; poisoning; using curcimim, caffeic acid and phenethyl ester |
| 08/26/2004 | US20040167215 Reducing toxicity; esterification; side effect reduction; skin disorders; wrinkle resistance; anticancer agents |
| 08/26/2004 | US20040167214 Method of identifying compounds suitable for treatment and/or prophylaxis of obesity |
| 08/26/2004 | US20040167213 Administering enzyme inhibitor; side effect reduction |
| 08/26/2004 | US20040167212 X-nitro compounds, pharmaceutical compositions thereof and uses thereof |
| 08/26/2004 | US20040167211 Methods of using substituted tetralins and indanes |
| 08/26/2004 | US20040167210 Crystalline base of citalopram |
| 08/26/2004 | US20040167209 Antidepressants; anxiolytic agents |
| 08/26/2004 | US20040167208 Anticancer agents; arteriosclerosis; psoriasis |
| 08/26/2004 | US20040167207 Synergistic mixture of vitamin k and warfarin |
| 08/26/2004 | US20040167206 Antiallergens; analgesics; using doxepin, or isomer thereof; side effect reduction |
| 08/26/2004 | US20040167205 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 08/26/2004 | US20040167204 Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotien and metalloenzyme targets |
| 08/26/2004 | US20040167203 Absorption enhancing agents |
| 08/26/2004 | US20040167202 Induction of immune tolerance |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167200 Inflammatory bowel disorders; pain therapy; anxiolytic agents; antidepressants; psychological disorders; autism; sleep disorders; amyotropic lateral sclerosis; cognition activators; eating disorders; administering nicotinic receptor antagonist |
| 08/26/2004 | US20040167199 Methods of using and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 08/26/2004 | US20040167198 Vasculostatic agents and methods of use thereof |
| 08/26/2004 | US20040167197 Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions |
| 08/26/2004 | US20040167196 Treatment of benign prostatic hyperplasia |
| 08/26/2004 | US20040167192 Modulate endothelia gene differentiation; antiproliferative agents; anticancer agents |
| 08/26/2004 | US20040167190 Prostagladin derivatives for the treatment of glaucoma or ocular hypertension |
| 08/26/2004 | US20040167189 Materials and methods for inhibiting Wip1 |
| 08/26/2004 | US20040167186 Use of certain crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide in treating epilepsy |
| 08/26/2004 | US20040167185 Methods of treating conditions associated with an Edg-3 receptor |
| 08/26/2004 | US20040167184 Treatment of lung cells with histone deacetylase inhibitors |
| 08/26/2004 | US20040167181 Modulation endothelial gene differentiation; antiproliferative agents; anticarcinogenic agents |
| 08/26/2004 | US20040167180 Anticancer agents |
| 08/26/2004 | US20040167179 Development of muscle mass in a mammal |
| 08/26/2004 | US20040167178 Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167175 Prevent transmission of disease; in bait, foods |
| 08/26/2004 | US20040167174 Substituted acylhydroxamic acids and method of reducing TNFalpha levels |
| 08/26/2004 | US20040167173 Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
| 08/26/2004 | US20040167172 Mixture of metformin and tyrosine phosphatase inhibitor |
| 08/26/2004 | US20040167171 Prevention, therapy of neurodegenerative disease; diffusion through brain, blood barrier; Alzheimer's, Parkinson's Huntington's diseases, Amyotrophic lateral sclerosis |
| 08/26/2004 | US20040167170 Methods of preventing breast cancer |
| 08/26/2004 | US20040167169 Antihistamines, antiallergens; bronchodilator |
| 08/26/2004 | US20040167167 Biphenyl derivatives |
| 08/26/2004 | US20040167166 Amino-piperidine derivatives |
| 08/26/2004 | US20040167165 moderator of endothelial gene differentiation receptors; anticancer agents |
| 08/26/2004 | US20040167164 Concurrent administering a-methyltyrosine and haloperidol |
| 08/26/2004 | US20040167162 therapy for infection of adenovirus, rhinovirus ; using an (amino or hydroxy)quinoline compound |
| 08/26/2004 | US20040167161 Using leukotrienes; diffusion blood brain barrier |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167159 Hemorrhoid therapeutic treatment |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167156 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 08/26/2004 | US20040167154 Urea substituted imidazoquinolines |
| 08/26/2004 | US20040167153 Synergistic mixture of phosphodiesterase inhibitor and adrenergic blocking agents; administering by breathing; respiratory system disorders; antiinflammatory agents |
| 08/26/2004 | US20040167152 Mixture of a rapamycin compound with cosolvent and antioxidant |
| 08/26/2004 | US20040167150 Treatment methods |
| 08/26/2004 | US20040167149 Aryl fused azapolycyclic compounds |
| 08/26/2004 | US20040167148 concurrent administering methadone |
| 08/26/2004 | US20040167147 Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid users |
| 08/26/2004 | US20040167146 mixture of analgesics; reducing dosage of devazepide |
| 08/26/2004 | US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers |
| 08/26/2004 | US20040167143 High speed metabolism; antiepileptic agents; anesthetics; central nervous system disorders; anxiolytic agents |
| 08/26/2004 | US20040167142 Pyrimidinone compounds |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167140 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/26/2004 | US20040167139 Methods of treating cancer |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167137 Xanthine phosphodiesterase V inhibitors |
| 08/26/2004 | US20040167135 Dihydropyrimidines |
| 08/26/2004 | US20040167134 Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167132 Edothelial differentiation gene modulation; controlling cell proliferation; anticancer agents |
| 08/26/2004 | US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/26/2004 | US20040167129 Novel CB 1 receptor inverse agonists |
| 08/26/2004 | US20040167125 such as sertindole, quetiapine and ziprasidone; use of combination to treat schizophrenia; synergistic mixture gives a more more rapid decrease in schizophrenic symptomology improving patient compliance |
| 08/26/2004 | US20040167117 Calcium channel blockers administered into nose |
| 08/26/2004 | US20040167114 Prevent apoptosis; synergistic mixture of zinc pyrithone and diethyldithiocarbamate; antiepileptic agents |
| 08/26/2004 | US20040167112 Use of estrogen receptor alpha modulators for the treatment of multiple sclerosis |
| 08/26/2004 | US20040167111 Reducing gonadotropin hormone side effects using estradiol compound |
| 08/26/2004 | US20040167110 Glucocorticoid receptor antagonist |
| 08/26/2004 | US20040167109 Using anecortave acetate |
| 08/26/2004 | US20040167108 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 08/26/2004 | US20040167107 Administering peroxisome proliferation activation receptors antagonist |
| 08/26/2004 | US20040167105 Osteoporosis; anticancer agents; autoimmune disease |
| 08/26/2004 | US20040167101 Novel quinolinones and uses thereof |
| 08/26/2004 | US20040167100 Illudin analogs useful as antitumor agents |
| 08/26/2004 | US20040167099 Mucoadhesive tetracycline formulations |
| 08/26/2004 | US20040167097 Antiproliferative agents; using synergistic mixture of epothilone and nucleoside |
| 08/26/2004 | US20040167096 Using a dideoxy and didehydro nucleoside |
| 08/26/2004 | US20040167095 Use of PDE V inhibitors for improved fecundity in mammals |
| 08/26/2004 | US20040167094 Using an adenosine-5'-N-methyluronamide compound |
| 08/26/2004 | US20040167093 Administering cytosine, creatine, adenosine |